TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11548448

Group type: EXPERIMENTAL
Intervention: Losartan (50-100 mg o.d.)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Captopril (25-50 mg b.i.d.)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Abrupt cessation of losartan and captopril
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 10087430

Group type: EXPERIMENTAL
Intervention: Warfarin managed by a nomogram
Number of subjects: 111

Group type: COMPARATOR
Intervention: Standard warfarin management by attending physicians
Number of subjects: 111
Study: 7921924

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus continuous oral chlorambucil (RT+CHL)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Radiotherapy alone (RT)
Number of subjects: 148
Study: 3139463

Group type: EXPERIMENTAL
Intervention: Follicle-stimulating hormone (FSH) (Metrodin, Serono Laboratories, Inc.)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Human menopausal gonadotropin (hMG) (Pergonal, Serono)
Number of subjects: 98
Study: 31226717

Group type: EXPERIMENTAL
Intervention: Guided de-escalation of dual antiplatelet treatment (DAPT)
Number of subjects: 2610
Study: 29112565

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation with oral antibiotics
Number of subjects: 190

Group type: COMPARATOR
Intervention: Mechanical bowel preparation
Number of subjects: 190
Study: 25803605

Group type: EXPERIMENTAL
Intervention: Eat Smart, Live Strong (ESLS) intervention
Number of subjects: 614
Study: 23890993

Group type: EXPERIMENTAL
Intervention: Bridge exercise with arm movement
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bridge exercise without arm movement
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bridging on the floor
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bridging on the ball
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bridging on the floor and on the ball
Number of subjects: 20
Study: 21531233

Group type: EXPERIMENTAL
Intervention: Bare metal stents followed by a 40-day prednisone treatment
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents
Number of subjects: 375

Group type: COMPARATOR
Intervention: Bare metal stents (controls)
Number of subjects: 375
Study: 19290533

Group type: EXPERIMENTAL
Intervention: Intraoperative extrapleural chest tube (EPCT) drainage, n = 21
Number of subjects: 50

Group type: COMPARATOR
Intervention: No intraoperative EPCT drainage, n = 29
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 16436648

Group type: EXPERIMENTAL
Intervention: Topiramate (400 mg/day target dose)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study: 15211369

Group type: EXPERIMENTAL
Intervention: 360 mg orlistat per day (group 1; n=30)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 360 mg orlistat plus 1700 mg metformin per day (group 2; n=27)
Number of subjects: 57
Study: 11581068

Group type: EXPERIMENTAL
Intervention: Depressive disorder (diagnosed using SCID-IV)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Visual acuity
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Geriatric Depression Scale (GDS)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: National Eye Institute-Vision Function Questionnaire (NEI-VFQ)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Sickness Impact Profile (SIPV)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Sickness Impact Profile-68 (SIP)
Number of subjects: 151
Study: 9477041

Group type: EXPERIMENTAL
Intervention: Micronized purified flavonoid fraction (Daflon 500 mg = Dios), 2 tablets/day for 2 months
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 7888231

Group type: COMPARATOR
Intervention: 160 micrograms rgp160 vaccine
Number of subjects: 56

Group type: COMPARATOR
Intervention: 640 micrograms rgp160 vaccine
Number of subjects: 56
Study: 3345623

Group type: EXPERIMENTAL
Intervention: Nisoldipine (oral)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nisoldipine (intravenous)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nisoldipine with cimetidine
Number of subjects: 8
Study: 28681057

Group type: EXPERIMENTAL
Intervention: FFR with EV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FFR with EV+AVS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard FFR
Number of subjects: 0
Study: 27647031

Group type: EXPERIMENTAL
Intervention: Automated pressure-controlled discography (APCD) before ALIF
Number of subjects: 36

Group type: COMPARATOR
Intervention: ALIF without APCD
Number of subjects: 36
Study: 25604762

Group type: EXPERIMENTAL
Intervention: LLIN curtains and water container covers
Number of subjects: 1225

Group type: EXPERIMENTAL
Intervention: LLIN water container covers
Number of subjects: 1225

Group type: COMPARATOR
Intervention: Routine vector control activities (Control)
Number of subjects: 1225
Study: 23901664

Group type: EXPERIMENTAL
Intervention: Interval training programme (8 weeks, 45-60 minutes)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Control (sedentary)
Number of subjects: 245
Study: 21371548

Group type: EXPERIMENTAL
Intervention: Gastroretentive tablet (GT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional tablet (CT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Co-administration of GT with CT
Number of subjects: 0
Study: 18321153

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 0
Study: 16741654

Group type: EXPERIMENTAL
Intervention: 100 mg intravenous thiamine
Number of subjects: 30

Group type: COMPARATOR
Intervention: No thiamine
Number of subjects: 30
Study: 14660990

Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 311

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 311
Study: 11913310

Group type: COMPARATOR
Intervention: Chewing gum containing 5% sodium bicarbonate (0 times daily - control)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Chewing gum containing 5% sodium bicarbonate (1 time daily)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Chewing gum containing 5% sodium bicarbonate (2 times daily)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Chewing gum containing 5% sodium bicarbonate (3 times daily)
Number of subjects: 88
Study: 9744587

Group type: EXPERIMENTAL
Intervention: Pre and post prandial Duplex colour Doppler sonographic measurement of superior mesenteric artery (SMA) flow after a food challenge (200 ml of Ensure Plus)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Systemic steroids introduced to patients with active Crohn's disease
Number of subjects: 36
Study: 8276648

Group type: EXPERIMENTAL
Intervention: LOW instantaneous dose rate (6 cGy/min single-dose)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: HIGH instantaneous dose rate (15 cGy/min single-dose)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Single-dose total-body irradiation
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Fractionated total-body irradiation
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Single-dose LOW
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Single-dose HIGH
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Fractionated LOW
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Fractionated HIGH
Number of subjects: 157

Group type: COMPARATOR
Intervention: Steroid treatment
Number of subjects: 157
Study: 2663164

Group type: EXPERIMENTAL
Intervention: Ketanserin (20 mg twice daily for two weeks, then 40 mg twice daily for three months)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Methyldopa (250 mg twice daily for two weeks, then 500 mg twice daily for three months)
Number of subjects: 30
Study: 8774

Group type: EXPERIMENTAL
Intervention: Hypertonic solutions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypertonic non-electrolyte solutions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31752969

Group type: EXPERIMENTAL
Intervention: Home-based delivery of barrier, short-acting, and long-acting contraceptives by trained community nurses during postpartum visits.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care including postpartum contraceptive education and counseling without home-based delivery of contraceptives.
Number of subjects: 0
Study: 28190252

Group type: EXPERIMENTAL
Intervention: Local reporting
Number of subjects: 1688

Group type: COMPARATOR
Intervention: Reviewed frequency
Number of subjects: 1688

Group type: COMPARATOR
Intervention: Initial central review
Number of subjects: 1688

Group type: COMPARATOR
Intervention: Online consensus review
Number of subjects: 1688
Study: 26852499

Group type: EXPERIMENTAL
Intervention: Hyperbaric gaseous cryotherapy in addition to traditional physical therapy, balneotherapy, therapeutic physical exercises, and massage.
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (traditional physical therapy, balneotherapy, therapeutic physical exercises, and massage without hyperbaric gaseous cryotherapy).
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Hyperbaric gaseous cryotherapy.
Number of subjects: 110
Study: 23221121

Group type: EXPERIMENTAL
Intervention: Performance-Based Financing (PBF) intervention
Number of subjects: 7899

Group type: COMPARATOR
Intervention: Control group (no PBF)
Number of subjects: 7899
Study: 21514932

Group type: EXPERIMENTAL
Intervention: EUS-FNA with a stylet
Number of subjects: 101

Group type: COMPARATOR
Intervention: EUS-FNA without a stylet
Number of subjects: 101
Study: 18496196

Group type: EXPERIMENTAL
Intervention: Intraoperative electrophysiological study
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: C5 and C6 nerve roots stimulation
Number of subjects: 27
Study: 16921043

Group type: COMPARATOR
Intervention: Single high-dose chemotherapy (HDT)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Tandem high-dose chemotherapy (HDT)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Complete remission after induction chemotherapy
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Three or more sites of metastases
Number of subjects: 187
Study: 15015647

Group type: EXPERIMENTAL
Intervention: Heparin-coated circuits (HCC)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (3 mg/kg heparin)
Number of subjects: 23
Study: 11110854

Group type: EXPERIMENTAL
Intervention: Reduced-phytate corn-plus-soy diet
Number of subjects: 23

Group type: COMPARATOR
Intervention: High phytate diet
Number of subjects: 23
Study: 9167099

Group type: EXPERIMENTAL
Intervention: Low-fat diet (30% daily energy intake) with one fish meal daily (3.6 g omega-3/day)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Moderate exercise (55-65% VO2max)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Fish diet
Number of subjects: 55

Group type: COMPARATOR
Intervention: Low-fat diet (30% daily energy intake) without fish
Number of subjects: 55
Study: 1350232

Group type: EXPERIMENTAL
Intervention: Azelastine, 4 mg twice daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Azelastine
Number of subjects: 12
Study: 30874803

Group type: EXPERIMENTAL
Intervention: Computerized working memory training (Standard; n=14)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Computerized working memory training plus parental problem-solving skills training (Combined; n=13)
Number of subjects: 27
Study: 29989385

Group type: EXPERIMENTAL
Intervention: General positive affect elicited through a writing task in Study 1
Number of subjects: 1943

Group type: EXPERIMENTAL
Intervention: Discrete positive emotions (elevation, humor, hubristic pride) in Study 2
Number of subjects: 1943

Group type: COMPARATOR
Intervention: Control condition in Study 2
Number of subjects: 1943
Study: 27557561

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study: 24562802

Group type: EXPERIMENTAL
Intervention: Non-obstructive CAD
Number of subjects: 37101

Group type: COMPARATOR
Intervention: Obstructive CAD
Number of subjects: 37101
Study: 23079176

Group type: EXPERIMENTAL
Intervention: Intervention participants receiving access to a physical activity-focused website with physical activity self-monitoring and enrollment in a Facebook group (n=67)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Education‐only controls receiving access to a physical activity‐focused website (n=67)
Number of subjects: 134
Study: 21154036

Group type: EXPERIMENTAL
Intervention: Dietary supplements to lower homocysteine
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Ruff 2 and 7 Selective Attention Test
Number of subjects: 234
Study: 17659078

Group type: EXPERIMENTAL
Intervention: Caregiver intervention for people with dementia and their families (randomised controlled trial)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Cross-sectional comprehensive surveys
Number of subjects: 2000
Study: 16159043

Group type: EXPERIMENTAL
Intervention: Audit/feedback with peer-derived benchmarks and continuing medical education
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 85
Study: 12017348

Group type: EXPERIMENTAL
Intervention: Fiduxosin 30 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Fiduxosin 60 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Fiduxosin 90 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 10418841

Group type: EXPERIMENTAL
Intervention: Urinary catheterization
Number of subjects: 40
Study: 7745048

Group type: EXPERIMENTAL
Intervention: Laparoscopic intervention with standardized adhesion scoring system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group with active agent or placebo placed in the peritoneal cavity
Number of subjects: 0
Study: 2048514

Group type: EXPERIMENTAL
Intervention: Midazolam/fentanyl
Number of subjects: 50

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 50
Study: 6799848

Group type: EXPERIMENTAL
Intervention: Piracetam (Nootropil)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Piritinol (Encephabol, Enerbol)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Piriditol
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Centrophenoxin
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Nootropil
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Encephabol
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Other drugs (not specified)
Number of subjects: 315
Study: 31109289

Group type: EXPERIMENTAL
Intervention: Telerehabilitation intervention (N=30)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Face-to-face home visits (N=30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (N=30)
Number of subjects: 90
Study: 28274941

Group type: EXPERIMENTAL
Intervention: Stepping Up model of care intervention
Number of subjects: 266

Group type: COMPARATOR
Intervention: Usual primary care (Control)
Number of subjects: 266
Study: 26469868

Group type: EXPERIMENTAL
Intervention: Effective Automatic Mechanical Peripheral Stimulation (AMPS)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Effective AMPS
Number of subjects: 11
Study: 24128075

Group type: EXPERIMENTAL
Intervention: Reinforcement intervention with chances to win $1-$100 prizes for meeting walking recommendations
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control condition with pedometers and guidelines to walk 10,000 steps/day
Number of subjects: 45
Study: 21410332

Group type: EXPERIMENTAL
Intervention: Video-based intervention providing information on contraceptive methods and modeling desirable future planning behaviors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 19840308

Group type: EXPERIMENTAL
Intervention: 308-nm Excimer laser treatment, applied twice a week for 12 weeks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control patches (not treated with the 308-nm Excimer laser)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: 308-nm Excimer laser treatment
Number of subjects: 9
Study: 18092260

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infliximab (standard dosage)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infliximab (double dosage)
Number of subjects: 0
Study: 15374764

Group type: EXPERIMENTAL
Intervention: Combined ergonomic and job stress intervention (ergonomic intervention plus two 1-h workshops on stress management)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ergonomics intervention (assessment and modification of work station and stretching exercises)
Number of subjects: 70
Study: 11153772

Group type: EXPERIMENTAL
Intervention: PTCR (Percutaneous Transluminal Coronary Revascularization)
Number of subjects: 450

Group type: COMPARATOR
Intervention: CABG (Coronary Artery Bypass Graft)
Number of subjects: 450
Study: 9039239

Group type: EXPERIMENTAL
Intervention: Montelukast 100 mg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Montelukast 250 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 7892950

Group type: EXPERIMENTAL
Intervention: Prostacyclin-thromboxane system assessment in newborns with perinatal hypoxia
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Chronic intrauterine hypoxia
Number of subjects: 122
Study: 3229870

Group type: EXPERIMENTAL
Intervention: Nilvadipine 4 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nilvadipine 8 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nilvadipine 12 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nilvadipine 16 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nilvadipine 20 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31538396

Group type: EXPERIMENTAL
Intervention: MSCopilot
Number of subjects: 141

Group type: COMPARATOR
Intervention: MSFC
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: MSCopilot and MSFC correlation
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: MSCopilot test-retest
Number of subjects: 141
Study: 31027060

Group type: EXPERIMENTAL
Intervention: Mirror Therapy (MT) for 30 minutes a day, 3 days a week for 4 weeks + conventional physical therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional physical therapy only
Number of subjects: 30
Study: 28652725

Group type: EXPERIMENTAL
Intervention: Aclidinium bromide 400 μg BID
Number of subjects: 277

Group type: COMPARATOR
Intervention: Tiotropium 18 μg QD
Number of subjects: 277

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 277
Study: 26136410

Group type: EXPERIMENTAL
Intervention: specific medical food for 4 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: routine care control arm (non-caloric placebo or iso-caloric control)
Number of subjects: 64
Study: 24157144

Group type: EXPERIMENTAL
Intervention: Multimodal cocktail periarticular injection with steroid
Number of subjects: 72

Group type: COMPARATOR
Intervention: Multimodal cocktail periarticular injection without steroid
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study: 21916908

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care (counselling on osteoporosis, risk factors, lifestyle modifications, goals of therapy, side effects, and importance of adherence)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no counselling)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care (counselling)
Number of subjects: 0
Study: 19673711

Group type: EXPERIMENTAL
Intervention: Bivalirudin monotherapy
Number of subjects: 6441

Group type: EXPERIMENTAL
Intervention: Bivalirudin plus GPI
Number of subjects: 6441

Group type: COMPARATOR
Intervention: Heparin plus GPI
Number of subjects: 6441
Study: 16509977

Group type: EXPERIMENTAL
Intervention: Case-based discussions including exercises that required managing new information
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard case discussions without information management exercises (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Third rotation students
Number of subjects: 0
Study: 15703139

Group type: EXPERIMENTAL
Intervention: High frequency (HF) PTA over 3, 4 and 6 kHz for adults not exposed to hazardous occupational noise
Number of subjects: 0
Study: 11742777

Group type: EXPERIMENTAL
Intervention: Nursing-led care with no routine medical intervention (n=89)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Usual hospital care (n=86)
Number of subjects: 175
Study: 9407512

Group type: EXPERIMENTAL
Intervention: High-flux polysulfone AN69 (HF) hemodialysis
Number of subjects: 25

Group type: COMPARATOR
Intervention: Low flux (LF) hemodialysis
Number of subjects: 25
Study: 8100152

Group type: EXPERIMENTAL
Intervention: Fenoldopam (FEN)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 20
Study: 3312450

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) inhalation aerosol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31277720

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0
Study: 27873451

Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (PIPC/TAZ) 337.5 mg/kg per day in three doses, 1-hr DIV, maximum 13.5 g per day
Number of subjects: 105

Group type: COMPARATOR
Intervention: Meropenem (MEPM) 120 mg/kg per day in three doses, 1-hr DIV, maximum 3 g per day
Number of subjects: 105
Study: 26519819

Group type: EXPERIMENTAL
Intervention: MiniArc®
Number of subjects: 44

Group type: COMPARATOR
Intervention: Monarc™
Number of subjects: 44
Study: 24598216

Group type: EXPERIMENTAL
Intervention: Remifentanil with an effect-site target concentration of 3 ng/ml
Number of subjects: 25

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Remifentanil and Saline (placebo)
Number of subjects: 25
Study: 22976604

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation (MBP)
Number of subjects: 79

Group type: COMPARATOR
Intervention: No mechanical bowel preparation (no-MBP)
Number of subjects: 79
Study: 19470037

Group type: EXPERIMENTAL
Intervention: Women receiving ICDs
Number of subjects: 1530
Study: 17305698

Group type: EXPERIMENTAL
Intervention: Restored with titanium posts
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Restored with cast post-and-cores
Number of subjects: 183

Group type: COMPARATOR
Intervention: Restored without post restorations (control)
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Overall complications
Number of subjects: 183